DOI: 10.11606/d.5.2013.tde-08082013-091918
|View full text |Cite
|
Sign up to set email alerts
|

Validação de um questionário para a avaliação da adesão ao tratamento antiviral em pacientes portadores de hepatite B crônica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…[1][2][3] According to the World Health Organization (WHO), approximately 2 billion people have been exposed to the virus. Of these, 240 million are estimated to have the chronic form of the disease.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[1][2][3] According to the World Health Organization (WHO), approximately 2 billion people have been exposed to the virus. Of these, 240 million are estimated to have the chronic form of the disease.…”
Section: Introductionmentioning
confidence: 99%
“…Pharmacological options for the treatment of hepatitis B are: interferon-alpha, lamivudine, peg-interferon-alpha 2a and 2b, adefovir, entecavir, telbivudine, and tenofovir. 1,5,6 Vertical hepatitis B transmission may occur during acute or chronic maternal infection through exposure of fetal mucous membranes to HBV-infected blood or maternal bodily fluids, which may occur before birth, transplacentally (intrauterinely) or at the time of childbirth (perinatally). Occasionally, the child's infection occurs in the postnatal period through contact with infected adults.…”
Section: Introductionmentioning
confidence: 99%